Academia Sinica academician Chen Pei-jer (陳培哲), who on Monday resigned from the vaccine review committee, has been accused of working as an adviser for a Shanghai-based Chinese pharmaceutical company.
Chen was allegedly listed as a “scientific adviser” on the Web site of Zhimeng Biopharma Inc (上海摯盟醫藥科技公司) in Shanghai, China, while he served as a committee member, sources said yesterday.
If the claims are true, it could mean Chen had contravened the law restricting government officials and employees from undertaking concurrent jobs in China and other countries.
Photo courtesy of Chen Pei-jer
Chen is also a professor at state-funded National Taiwan University (NTU) and a medical researcher at NTU Hospital.
Chen yesterday said he was not in a paid position at the Chinese firm.
He showed a letter from Zhimeng Biopharma stating that Chen’s scientific adviser role is an honorary title without any responsibility, obligation or payment, and “purely scientific advancement.”
However, critics said Chen and the company were trying to cover up their ties.
When resigning from the committee, Chen accused President Tsai Ing-wen (蔡英文) of pressuring the body to expedite the approval of the MVC-COV1901 vaccine being developed by Medigen Vaccine Biologics.
Citing his reasons for resigning his post, Chen said he believed the committee would have trouble staying neutral when reviewing domestic vaccine candidates.
The main problem was Tsai, as she said a locally developed COVID-19 vaccine is expected to be available late next month, Chen said, insinuating that the Food and Drug Administration could not resist pressure from the president and would expedite the vaccine’s approval.
New Taipei City Councilor Ho Po-wen (何博文) of the Democratic Progressive Party yesterday accused Chen of working to benefit China by sabotaging Taiwan’s vaccine development efforts.
Ho presented documents allegedly showing that Chen had close ties with universities and biotechnology companies in China, including Xiamen University.
Ho also said that Chen timed his resignation and public accusations just before the completion of phase 2 clinical trials of the vaccine, with Medigen scheduled to announce results of human trials soon.
“Chen is undermining Taiwan’s own COVID-19 vaccine to prevent it from reaching production. In his position as a committee member and a medical expert, he is saying Medigen’s vaccine is doomed to failure, and it would not pass clinical trials,” Ho said.
PRIORITY GROUPS: A line of people were waiting at the Good Liver Clinic, apparently to get shots, while the CECC announced more priority groups for jabs The Taipei-based Good Liver Clinic is to be fined NT$2 million (US$72,028) after giving free COVID-19 vaccine shots to people not in groups eligible to receive them, Taipei Deputy Mayor Vivian Huang (黃珊珊) said yesterday. The Zhongshan District (中山)-based clinic was removed from the city’s list of vaccination venues and health officials would be investigated for giving 1,113 doses to the clinic, Huang told an afternoon news conference at Taipei City Hall. The Chinese-language Liberty Times (the Taipei Times’ sister paper) on Tuesday in an exclusive story citing an anonymous tip reported that a Taipei clinic was doling out unused vaccines. People in
PHASE 2: The firm’s CEO said that the results were good and the experimental vaccine safe, but added that hoped-for phase 3 trials would be expensive Medigen Vaccine Biologics Corp (高端疫苗) yesterday reported positive results from an interim analysis of phase 2 trials for its COVID-19 vaccine, saying that the vaccine demonstrated high seroconversion rates and geometric mean titer (GMT) figures. A seroconversion rate is the percentage of participants in a trial displaying virus-specific immune memory after being given a vaccine, while the GMT measures the level of neutralizing antibody response, Medigen said. The experimental vaccine has a seroconversion rate of 99.8 percent and its GMT was 662 among the participants aged 20 to 89, while the gauges rose to 99.9 percent and 733 respectively in participants aged
ROLLING OUT DOSES: The expansion aims to speed up Taiwan’s vaccination drive by making more Moderna jabs available to workers at hospitals, the CECC said The Central Epidemic Command Center (CECC) yesterday expanded the eligibility for the Moderna COVID-19 vaccine to all healthcare workers and non-healthcare workers in the highest vaccine priority group. The center said that 75,000 doses of the vaccine — half of the first batch Taiwan has received — were on Wednesday distributed to hospitals across the nation with specialized COVID-19 rooms, negative pressure wards and testing services. Thus far, they had only been offered to frontline healthcare workers and non-healthcare workers at the designated hospitals, it said. Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, said that the eligibility was
NUMBERS HAVE FALLEN: Minister of Health and Welfare Chen Shih-chung said there are good signs, but ‘we cannot afford to let our guard down now’ The Central Epidemic Command Center (CECC) yesterday reported 219 new locally transmitted COVID-19 infections and 22 deaths. Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, said that the 219 local infections — 117 male and 102 female — were aged from under five to over 100 years old, and they began having symptoms between May 22 and Monday. New Taipei City reported 123 cases, followed by Taipei with 54, Miaoli County with 16, Taoyuan with 13, Keelung with eight, Changhua County with two, and one each in Hsinchu City, Taichung and Tainan. The 22 deaths were 15 men and